buspirone has been researched along with Smoking Cessation in 9 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred one smokers were divided into high and low trait anxiety groups on the basis of a normalized score on the Profile of Mood States Anxiety/Tension Scale and were randomly assigned to receive buspirone or placebo in a double-blind fashion." | 9.08 | A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. ( Cinciripini, PM; Lapitsky, L; Meyer, WJ; Seay, S; van Vunakis, H; Wallfisch, A, 1995) |
| "Buspirone, a non-sedating anxiolytic, has yielded contradictory results in smoking cessation pilot studies and trials." | 9.08 | Efficacy of buspirone in smoking cessation: a placebo-controlled trial. ( Brown, HV; Daims, RM; Olmstead, RE; Schneider, NG; Sloan, K; Steinberg, C, 1996) |
| "Before smoking cessation, there were no significant differences in the intensity of any withdrawal symptom between the buspirone- and placebo-treated subjects, with the exception of a significantly higher rating for drowsiness in the buspirone group." | 9.07 | Effect of buspirone on withdrawal symptoms associated with smoking cessation. ( Del Core, MG; Hilleman, DE; Mohiuddin, SM; Sketch, MH, 1992) |
| "Buspirone was started 21 days before the quit attempt and continued for 7 days after the quit attempt." | 6.67 | Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation. ( Delcore, MG; Hilleman, DE; Mohiuddin, SM, 1994) |
| "Buspirone, a non-sedating anxiolytic, has yielded contradictory results in smoking cessation pilot studies and trials." | 5.08 | Efficacy of buspirone in smoking cessation: a placebo-controlled trial. ( Brown, HV; Daims, RM; Olmstead, RE; Schneider, NG; Sloan, K; Steinberg, C, 1996) |
| "Before smoking cessation, there were no significant differences in the intensity of any withdrawal symptom between the buspirone- and placebo-treated subjects, with the exception of a significantly higher rating for drowsiness in the buspirone group." | 5.07 | Effect of buspirone on withdrawal symptoms associated with smoking cessation. ( Del Core, MG; Hilleman, DE; Mohiuddin, SM; Sketch, MH, 1992) |
| "Clonidine was the first non-nicotine medication to show efficacy for smoking cessation in multiple studies, but its effect was found to be limited at best." | 2.41 | Advances in non-nicotine pharmacotherapy for smoking cessation. ( Adams, DP; Covey, LS; Glassman, AH; Johnston, JA; Robinson, MD; Sullivan, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrão, JL | 1 |
| Moreira, LB | 1 |
| Fuchs, FD | 1 |
| Cinciripini, PM | 1 |
| Lapitsky, L | 1 |
| Seay, S | 1 |
| Wallfisch, A | 1 |
| Meyer, WJ | 1 |
| van Vunakis, H | 1 |
| Hilleman, DE | 2 |
| Mohiuddin, SM | 2 |
| Delcore, MG | 1 |
| Schneider, NG | 1 |
| Olmstead, RE | 1 |
| Steinberg, C | 1 |
| Sloan, K | 1 |
| Daims, RM | 1 |
| Brown, HV | 1 |
| Bevelaqua, FA | 1 |
| Farid, P | 1 |
| Abate, MA | 1 |
| Covey, LS | 1 |
| Sullivan, MA | 1 |
| Johnston, JA | 1 |
| Glassman, AH | 1 |
| Robinson, MD | 1 |
| Adams, DP | 1 |
| Del Core, MG | 1 |
| Sketch, MH | 1 |
2 reviews available for buspirone and Smoking Cessation
| Article | Year |
|---|---|
Buspirone use for smoking cessation.
Topics: Adult; Anti-Anxiety Agents; Buspirone; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; | 1998 |
Advances in non-nicotine pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Bupropion; Buspirone; Clonidine; Humans; Moclobemide; Narcotic Antagonists; S | 2000 |
5 trials available for buspirone and Smoking Cessation
| Article | Year |
|---|---|
The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.
Topics: Adolescent; Adult; Aged; Buspirone; Chi-Square Distribution; Cognitive Behavioral Therapy; Double-Bl | 2007 |
A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.
Topics: Adult; Aged; Anxiety; Buspirone; Double-Blind Method; Humans; Middle Aged; Patient Compliance; Psych | 1995 |
Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Buspirone; Drug Administration Schedule; Female; | 1994 |
Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Buspirone; Double-Blind Method; Female; Humans; Male; Middle Ag | 1996 |
Effect of buspirone on withdrawal symptoms associated with smoking cessation.
Topics: Adult; Buspirone; Double-Blind Method; Female; Humans; Male; Middle Aged; Smoking Cessation; Substan | 1992 |
2 other studies available for buspirone and Smoking Cessation
| Article | Year |
|---|---|
Buspirone:seven-year update.
Topics: Buspirone; Geriatrics; Humans; Mental Disorders; Primary Health Care; Smoking Cessation | 1994 |
Possible role of buspirone hydrochloride in smoking cessation.
Topics: Administration, Cutaneous; Buspirone; Humans; Serotonin Receptor Agonists; Smoking Cessation; Treatm | 1997 |